financetom
Forex World Market Business Cryptocurrency Commodities MAP
financetom
Business
financetom
/
Business
/
Orezone Gold Secures US$105 Million Financing to Fully Fund the Bombore Phase II Hard Rock Expansion
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Orezone Gold Secures US$105 Million Financing to Fully Fund the Bombore Phase II Hard Rock Expansion
Jul 10, 2024 4:01 AM

06:39 AM EDT, 07/10/2024 (MT Newswires) -- Orezone Gold Corporation ( ORZCF ) secured Tuesday binding commitments totaling over US$105 million to fully finance the construction of the Phase II hard rock expansion at its flagship Bombore Gold Mine.

The board approved a "positive construction decision" for this brownfield expansion, the company said in a statement said.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
BRIEF-7-Eleven Owner Taps Nomura To Advise On Takeover Battle After Rejecting $39Bn Offer- FT
BRIEF-7-Eleven Owner Taps Nomura To Advise On Takeover Battle After Rejecting $39Bn Offer- FT
Sep 13, 2024
Sept 11 (Reuters) - * 7-ELEVEN OWNER TAPS NOMURA TO ADVISE ON TAKEOVER BATTLE AFTER REJECTING $39BN OFFER- FT Source text: https://tinyurl.com/2a5q7k6a Further company coverage: [3382.T ATD.TO 8604.T] ...
 BRIEF-Aprinoia Therapeutics Anticipate Initial Public Offering Price Per Share Will Be Between $10.00 And $12.00
BRIEF-Aprinoia Therapeutics Anticipate Initial Public Offering Price Per Share Will Be Between $10.00 And $12.00
Sep 13, 2024
Sept 11 (Reuters) - Aprinoia Therapeutics: * APRINOIA THERAPEUTICS INC.: ANTICIPATE INITIAL PUBLIC OFFERING PRICE PER SHARE WILL BE BETWEEN $10.00 AND $12.00 Source text for Eikon: ...
 Bicara Therapeutics targets $265 mln proceeds in upsized US IPO
Bicara Therapeutics targets $265 mln proceeds in upsized US IPO
Sep 13, 2024
Sept 11 (Reuters) - Bicara Therapeutics, a TPG-backed biopharmaceutical company developing a therapy targeting tumors, said on Wednesday it plans to raise up to $265 million through an upsized initial public offering (IPO) in the United States. This marks an increase from the previous target of raising up to $212 million. Expectations of a forthcoming rate cut is motivating several...
 BRIEF-Future Vision II Acquisition Announces Pricing Of $50,000,000 Initial Public Offering
BRIEF-Future Vision II Acquisition Announces Pricing Of $50,000,000 Initial Public Offering
Sep 13, 2024
Sept 11 (Reuters) - Future Vision II Acquisition Corp : * FUTURE VISION II ACQUISITION CORP. ANNOUNCES PRICING OF $50,000,000 INITIAL PUBLIC OFFERING Source text for Eikon: Further company coverage: ...
About
Terms and Conditions Privacy policy Cookie Settings Contact Us
Services
Login register
financetom Market Personal Finance Business Economy Cryptocurrency MAP
Links
zpostcode Recruit weather mreligion Yellowpages sport constellation shopping name game directory literature Word tour furnish Lottery tftnews lyrics News digital car dir Edu Finance
Copyright 2023-2026 - www.financetom.com All Rights Reserved